| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aktis Oncology, Inc. | 10%+ Owner | Common Stock | 10,260,064 | $219,052,366 | $21.35 | 12 Jan 2026 | Indirect |
| Entrada Therapeutics, Inc. | 10%+ Owner | Common Stock | 4,381,062 | $88,628,884 | $20.23 | 11 Dec 2024 | Indirect |
| iTeos Therapeutics, Inc. | Former 10% Owner | Common Stock | 2,108,594 | $16,995,267 | $8.06 | 13 May 2025 | Indirect |
| Aktis Oncology, Inc. | 10%+ Owner | Series A Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect | ||
| Aktis Oncology, Inc. | 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect | ||
| Aktis Oncology, Inc. | 10%+ Owner | Series Seed Redeemable Convertible Preferred Stock | 0 | 12 Jan 2026 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | 12 Jan 2026 | 7 | +$20,029,986 | 4 | 10%+ Owner | 14 Jan 2026, 18:19 |
| AKTS | Aktis Oncology, Inc. | 08 Jan 2026 | 0 | $0 | 3 | 10%+ Owner | 08 Jan 2026, 21:04 |
| ITOS | iTeos Therapeutics, Inc. | 13 May 2025 | 1 | -$5,079,339 | 4 | Former 10% Owner | 15 May 2025, 17:33 |
| TRDA | Entrada Therapeutics, Inc. | 10 Dec 2024 | 2 | -$917,111 | 4 | 10%+ Owner | 12 Dec 2024, 17:00 |
| ITOS | iTeos Therapeutics, Inc. | 04 Jan 2022 | 5 | -$6,246,050 | 4 | 10%+ Owner | 06 Jan 2022, 15:13 |
| ITOS | iTeos Therapeutics, Inc. | 03 Dec 2021 | 9 | -$1,680,611 | 4 | 10%+ Owner | 07 Dec 2021, 17:36 |
| ITOS | iTeos Therapeutics, Inc. | 30 Nov 2021 | 7 | -$2,878,562 | 4 | 10%+ Owner | 02 Dec 2021, 17:56 |
| ITOS | iTeos Therapeutics, Inc. | 26 Nov 2021 | 4 | -$810,766 | 4 | 10%+ Owner | 30 Nov 2021, 15:57 |
| ITOS | iTeos Therapeutics, Inc. | 17 Nov 2021 | 8 | -$2,835,263 | 4 | 10%+ Owner | 24 Nov 2021, 17:35 |
| TRDA | Entrada Therapeutics, Inc. | 02 Nov 2021 | 5 | +$2,000,000 | 4 | 10%+ Owner | 04 Nov 2021, 17:38 |
| TRDA | Entrada Therapeutics, Inc. | 28 Oct 2021 | 0 | $0 | 3 | 10%+ Owner | 28 Oct 2021, 20:47 |
| ITOS | iTeos Therapeutics, Inc. | 15 Oct 2021 | 3 | -$469,309 | 4 | 10%+ Owner | 18 Oct 2021, 16:35 |
| ITOS | iTeos Therapeutics, Inc. | 12 Oct 2021 | 3 | -$1,544,474 | 4 | 10%+ Owner | 14 Oct 2021, 17:28 |
| ITOS | iTeos Therapeutics, Inc. | 07 Oct 2021 | 3 | -$1,415,546 | 4 | 10%+ Owner | 12 Oct 2021, 16:34 |
| ITOS | iTeos Therapeutics, Inc. | 01 Oct 2021 | 2 | -$745,525 | 4 | 10%+ Owner | 05 Oct 2021, 16:33 |
| ITOS | iTeos Therapeutics, Inc. | 28 Sep 2021 | 2 | -$580,662 | 4 | 10%+ Owner | 30 Sep 2021, 17:06 |
| ITOS | iTeos Therapeutics, Inc. | 23 Sep 2021 | 4 | -$1,484,416 | 4 | 10%+ Owner | 27 Sep 2021, 17:52 |
| ITOS | iTeos Therapeutics, Inc. | 21 Sep 2021 | 2 | -$933,030 | 4 | 10%+ Owner | 23 Sep 2021, 16:19 |
| ITOS | iTeos Therapeutics, Inc. | 16 Sep 2021 | 4 | -$2,590,097 | 4 | 10%+ Owner | 20 Sep 2021, 18:37 |
| ITOS | iTeos Therapeutics, Inc. | 14 Sep 2021 | 4 | -$1,264,910 | 4 | 10%+ Owner | 16 Sep 2021, 16:46 |
| ITOS | iTeos Therapeutics, Inc. | 09 Sep 2021 | 4 | -$1,632,261 | 4 | 10%+ Owner | 13 Sep 2021, 18:59 |
| ITOS | iTeos Therapeutics, Inc. | 07 Sep 2021 | 4 | -$1,235,644 | 4 | 10%+ Owner | 08 Sep 2021, 19:12 |